Human wild type p53 inhibits cell proliferation and elicits dramatic morphological changes in human glioma cell lines in vitro.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Neurological Sciences

• Publication date

  1994-12-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0022-510X(94)90064-7PMID 7707071
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1.

  1994cited by this paper
• Growth suppression mediated by transfection of p53 in Hut292DM human lung cancer cells expressing endogenous wild-type p53 protein.

  1992cited by this paper
• Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme.

  1992cited by this paper
• p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.

  1992cited by this paper
• Clonal expansion of p53 mutant cells is associated with brain tumour progression

  1992cited by this paper
• Cooperation between the H-ras oncogene and a truncated derivative of the v-myb oncogene in transformation of hamster embryo fibroblasts.

  1992cited by this paper
• TP53 Gene Mutations and 17p Deletions in Human Astrocytomas

  1991cited by this paper
• Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

  1991cited by this paper
• Multiple sequential molecular abnormalities in the evolution of human gliomas.

  1991cited by this paper
• Involvement of wild-type p53 in pre-B-cell differentiation in vitro.

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

  1990cited by this paper
• Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer.

  1990cited by this paper
• Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

  1990cited by this paper
• Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.

  1990cited by this paper
• Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53.

  1990cited by this paper
• Cytogenetics and Molecular Genetics of Malignant Gliomas and Medulloblastoma

  1990cited by this paper
• Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome

  1990cited by this paper
• A human glioma cell line retaining expression of GFAP and gangliosides, recognized by A2B5 and LB1 antibodies, after prolonged passage

  1990cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper
• Loss of distinct regions on the short arm of chromosome 17 associated with tumorigenesis of human astrocytomas.

  1989cited by this paper
• Mitotic recombination of chromosome 17 in astrocytomas.

  1989cited by this paper
• Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma.

  1989cited by this paper
• Pathology of Tumours of the Nervous System

  1960cited by this paper

• All-trans retinoic acid upregulates the expression of p53 via Axin and inhibits the proliferation of glioma cells.

  2013cites this paper
• Sensitivity to and functional effects of tricyclic agents on glioma: an immunohistochemical and in vitro study

  2011cites this paper
• Novel Perspectives on p53 Function in Neural Stem Cells and Brain Tumors

  2010cites this paper
• Generalized Death of Human Glioma Cells via Apoptosis Gene Produces Rapid p 53 Adenovirus-mediated Transfer of the Updated Version

  2006cites this paper
• pRb2/p130 gene overexpression induces astrocyte differentiation.

  2001cites this paper
• Delivery of Cell Cycle Genes to Block Astrocytoma Growth

  2001cites this paper
• Mutation detection by pyrosequencing: sequencing of exons 5-8 of the p53 tumor suppressor gene.

  2000cites this paper
• Effects of clotrimazole on the growth, morphological characteristics, and cisplatin sensitivity of human glioblastoma cells in vitro.

  1999cites this paper
• Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule

  1999cites this paper
• Restoration of wild-type PTEN expression leads to apoptosis, induces differentiation, and reduces telomerase activity in human glioma cells.

  1999cites this paper
• Chemosensitivity of human malignant glioma: modulation by p53 gene transfer

  1998cites this paper
• Transfection of C6 glioma cells with the bax gene and increased sensitivity to treatment with cytosine arabinoside.

  1998cites this paper
• Tumor Suppressor Gene Therapy for Brain Tumors

  1998cites this paper
• The impact of p53 tumor suppressor gene on glioma biology.

  1997cites this paper
• Transfection of C6 glioma cells with the bax gene and increased sensitivity to treatment with cytosine arabinoside.

  1997cites this paper
• Molecular and cellular pathology of intrinsic brain tumours

  1997cites this paper
• Molecular characterization of glioblastoma cell differentiation.

  1997cites this paper
• Induction of differentiation by wild-type p53 gene in a human glioma cell line

  1997cites this paper
• Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis.

  1996cites this paper
• Adenovirus-based transfer of wild-type p53 gene increases ovarian tumor radiosensitivity.

  1996cites this paper
• Adenovirus‐mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo

  1996cites this paper
• Transfection of wild-type TP53 induces differentiation in human gingival carcinoma cells.

  1996cites this paper
• Gene Therapy for Brain Tumors

  1995cites this paper
• Extracellular matrix proteins inhibit proliferation, upregulate migration and induce morphological changes in human glioma cell lines.

  1995cites this paper